What is the recommended treatment for rat lungworm (Angiostrongylus cantonensis) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Rat Lungworm (Angiostrongylus cantonensis) Infection

The recommended treatment for rat lungworm infection is a 2-week course of high-dose corticosteroids combined with albendazole, which reduces symptom duration and severity while managing the inflammatory response that causes neurological damage. 1, 2

First-Line Treatment Regimen

  • Corticosteroids for 2 weeks are the cornerstone of therapy, with strong evidence showing they shorten the duration and severity of symptoms by controlling the inflammatory response in the central nervous system. 2

  • Albendazole should be added to corticosteroids based on evidence that the combination provides better outcomes than either agent alone, particularly in severe infections with high parasite burden. 3, 2, 4

  • The recent 2025 outbreak cases in Brazil successfully used albendazole combined with ivermectin and corticosteroids for 2 weeks, with both patients achieving complete neurological recovery and normal CSF parameters within 2 weeks. 3

  • Gabapentin should be added for management of neuropathic pain, which is a prominent and debilitating symptom in many patients. 3

Dosing Specifics

  • Albendazole 400 mg orally is the standard dose, though the exact duration (single dose vs. 2 weeks) varies by severity. 1, 3

  • Ivermectin 200 mcg/kg as a single oral dose can be added to the regimen, particularly in severe cases, based on recent clinical experience. 5, 3

  • High-dose corticosteroids (typically prednisolone) for 14 days, with the exact dose tailored to severity of meningitis. 2

Diagnostic Confirmation

  • The diagnosis requires recognizing the clinical triad: neurological syndrome with headache/neck stiffness/paresthesia, eosinophils in CSF or blood (typically 27-35% in CSF), and exposure history to raw/undercooked snails, slugs, or contaminated produce. 3, 2

  • Real-time PCR detection of parasite DNA in CSF provides definitive confirmation when available. 1

  • Serologic testing by ELISA and Western blot on CSF can confirm diagnosis. 3

  • MRI may show subtle leptomeningeal enhancement but is not always positive. 3

Critical Clinical Considerations

  • The therapeutic strategy should be tailored to illness severity: mild infections with low CSF eosinophil counts may respond to anti-inflammatory therapy alone, while severe infections require combined anthelmintic and anti-inflammatory treatment. 4

  • Anthelmintic agents have shown limited efficacy in some studies, with one review stating they "have not shown efficacy in human infection," emphasizing supportive care with inflammation and intracranial pressure management. 6

  • However, more recent evidence from 2021 and 2025 supports albendazole use, particularly when combined with corticosteroids, representing an evolution in treatment approach. 1, 3

Common Pitfalls to Avoid

  • Do not delay corticosteroid therapy while awaiting diagnostic confirmation if clinical suspicion is high, as early treatment is more effective than later intervention. 2, 7

  • Obtain culturally sensitive exposure history, particularly regarding ritual ingestion of slugs in religious ceremonies, which may not be volunteered without appropriate questioning. 3

  • Do not dismiss the diagnosis when initial presentations mimic other conditions (UTI, gout) that fail to explain the full neurological picture. 3

  • Monitor for long-term sequelae as some patients develop persistent neurological symptoms requiring extended follow-up. 1

Follow-up and Monitoring

  • Repeat CSF analysis within 2 weeks of treatment initiation to document improvement in eosinophil counts and protein levels. 3

  • Continue outpatient follow-up for neurological recovery assessment and management of any persistent neuropathic pain. 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.